您的位置: 首页 > 农业专利 > 详情页

Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
专利权人:
Sanofi
发明人:
Schwink, Lothar,Buning, Christian,Glombik, Heiner,Gossel, Matthias,Kadereit, Dieter,Halland, Nis,Lohmann, Matthias,Poverlein, Christoph,Ritter, Kurt
申请号:
AU2015239022
公开号:
AU2015239022A1
申请日:
2015.04.02
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present invention relates to isoindolinone compounds. The isoindolinone compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of isoindolinone compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充